A Pfizer executive testified before Congress on Tuesday that Pfizer expects to deliver 13 million doses of COVID-19 vaccine to the United States every week by mid-March, more than double the shipment volume in early February. hearing.
Pfizer Chief Commercial Officer John Young said that so far, Pfizer has shipped about 40 million doses to various parts of the United States and is expected to deliver 1
PFIZER says the South African variant can greatly reduce the protection of vaccine 19
He added that Pfizer is also preparing to provide 300 million injections to the United States by the end of July and increase its global production forecast in 2021 to at least 2 billion injections.
In preparation for his speech, Moderna president Stephen Hoge said that the drugmaker plans to deliver 100 million doses of two doses by the end of March and 300 million doses by the end of July.
|Ribonucleic acid||MODERNA INC.||159.37||-15.37||-8.80%|
|Jiangnan||Johnson and Johnson||161.87||-0.10||-0.06%|
Richard Nettles, vice president of medical affairs, said Johnson & Johnson believes that after obtaining US regulatory approval, it will be able to inject at least 20 million single doses into the United States by the end of March. It said it expects to ship 100 million doses by mid-2021.
For COVID-19 survivors, there may be only one shot, preliminary research shows
The drug maker’s comments make the United States expected to receive 240 million doses of vaccine by the end of March, enough to vaccinate 130 million Americans, and 700 million doses of vaccine by mid-year, enough to dose the entire American population.
These comments were prepared before the U.S. Congressional hearing on vaccine supply held by the House Energy and Commerce Committee on Tuesday.
Click here to read more about FOX business